Insider · CIK 0001244823
James B Breitmeyer
Files at VXRT (Vaxart, Inc.). First filing -, latest -.
In brief
James B Breitmeyer files SEC Form 4 as director at VXRT (Vaxart, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; James B Breitmeyer has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | VXRT Vaxart, Inc. | AGrant or award Common Stock | +8,315 | $0.00 | $0 | 87,115 | Jul 17, 2026 |
| Jul 16, 2026 | VXRT Vaxart, Inc. | AGrant or award Stock Options (right to buy)derivative | +16,610 | $0.00 | $0 | 16,610 | Jul 17, 2026 |
| Apr 23, 2026 | VXRT Vaxart, Inc. | AGrant or award Common Stock | +78,800 | $0.00 | $0 | 78,800 | May 1, 2026 |
| Apr 23, 2026 | VXRT Vaxart, Inc. | AGrant or award Stock Option (right to buy)derivative | +157,400 | $0.00 | $0 | 157,400 | May 1, 2026 |
Questions about James B Breitmeyer
Answered from the filings on this page, as of the latest one.
Is James B Breitmeyer buying or selling?
James B Breitmeyer has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did James B Breitmeyer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James B Breitmeyer has 0.
Where does James B Breitmeyer file Form 4?
James B Breitmeyer has filed Form 4 at VXRT (Vaxart, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.